Crescent Biopharma, Inc. (CBIO)

NASDAQ: CBIO · Real-Time Price · USD

16.60

-0.30 (-1.78%)

At close: Jun 27, 2025, 4:00 PM

15.90

-0.70 (-4.22%)

After-hours: Jun 27, 2025, 4:00 PM EDT

Crescent Biopharma Analyst Ratings

Total Analysts

2

Consensus Rating

Strong Buy

Price Target

$25.00

Upside

+50.60%

Ratings History

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Stephen Willey Stifel	Stifel	Strong Buy Initiates $28	Strong Buy	Initiates	$28	+68.67%	Jun 25, 2025
Charles Zhu LifeSci Capital	LifeSci Capital	Buy Initiates $22	Buy	Initiates	$22	+32.53%	Jun 18, 2025
Timur Ivannikov Raymond James	Raymond James	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Nov 15, 2021
Steven Seedhouse Raymond James	Raymond James	Buy Maintains $285 → $270	Buy	Maintains	$285 → $270	+1,526.51%	Aug 6, 2021
Timur Ivannikov Raymond James	Raymond James	Buy Maintains $270 → $285	Buy	Maintains	$270 → $285	+1,616.87%	Apr 29, 2021
Tyler Van Buren Piper Sandler	Piper Sandler	Buy Initiates $225	Buy	Initiates	$225	+1,255.42%	Feb 10, 2021
David Novak Raymond James	Raymond James	Buy Maintains $300 → $270	Buy	Maintains	$300 → $270	+1,526.51%	Feb 4, 2021
George Zavoico B. Riley Securities	B. Riley Securities	Strong Buy → Hold Downgrades $660 → $188	Strong Buy → Hold	Downgrades	$660 → $188	+1,029.52%	Jun 21, 2018
George Zavoico B. Riley Securities	B. Riley Securities	Strong Buy Maintains $285 → $735	Strong Buy	Maintains	$285 → $735	+4,327.71%	Feb 12, 2018
Madhu Kumar Chardan Capital	Chardan Capital	Strong Buy Maintains $150 → $1,125	Strong Buy	Maintains	$150 → $1,125	+6,677.11%	Feb 9, 2018
George Zavoico B. Riley Securities	B. Riley Securities	Strong Buy Initiates $285	Strong Buy	Initiates	$285	+1,616.87%	Dec 8, 2017
Madhu Kumar Chardan Capital	Chardan Capital	Strong Buy Initiates $150	Strong Buy	Initiates	$150	+803.61%	Jun 12, 2017
Kevin DeGeeter Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy Initiates $165	Strong Buy	Initiates	$165	+893.98%	Jun 6, 2017